Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_868bdadbe77158f13b5641fd755bd602 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-507 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1225 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-40 |
filingDate |
2015-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8de857ec6a031c4dd438e14bd22b3ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794bbe1f16dfcfda28e6a556e161982b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7339ccd47e5b4afc0890a4580bf42ef |
publicationDate |
2015-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2015153685-A1 |
titleOfInvention |
Humanized pertussis antibodies and uses thereof |
abstract |
The present invention relates to humanized antibodies which bind the pertussis toxin protein and their use as therapeutic agents. In particular, the present invention is directed to improved humanized 1B7 and 11E6 antibodies which bind the pertussis toxin protein. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11266688-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10538579-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3492497-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019526275-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7195253-B2 |
priorityDate |
2014-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |